Clinical benefit and cost effectiveness of endoscopic sinus surgery (ESS) in adult patients with chronic rhinosinusitis with nasal polyps (CRSwNP)
- Conditions
- Rhinosinusitis (rhinosinusistis)surgery (chirurgie)drug treatment ( medicamenteuze behandeling)nasal polyps (neuspoliepen)
- Registration Number
- NL-OMON24555
- Lead Sponsor
- Amsterdam Medical Centre, Department of Ear-, Nose- and Throat (ENT)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 238
Inclusion Criteria
Informed consent
Bilateral CRSwNP (nasal polyps)
Exclusion Criteria
1. Inability to comply with study protocol
2. Septal surgery without ESS
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary clinical endpoint is HRQol in CRSwNP patients, measured by the SNOT-22 at 12 months follow-up. HRQol is a<br>frequently used clinical endpoint in CRS clinical trials.
- Secondary Outcome Measures
Name Time Method